Increased glucose metabolism in TAMs fuels O-GlcNAcylation of lysosomal Cathepsin B to promote cancer metastasis and chemoresistance
- PMID: 36084651
- DOI: 10.1016/j.ccell.2022.08.012
Increased glucose metabolism in TAMs fuels O-GlcNAcylation of lysosomal Cathepsin B to promote cancer metastasis and chemoresistance
Abstract
How glucose metabolism remodels pro-tumor functions of tumor-associated macrophages (TAMs) needs further investigation. Here we show that M2-like TAMs bear the highest individual capacity to take up intratumoral glucose. Their increased glucose uptake fuels hexosamine biosynthetic pathway-dependent O-GlcNAcylation to promote cancer metastasis and chemoresistance. Glucose metabolism promotes O-GlcNAcylation of the lysosome-encapsulated protease Cathepsin B at serine 210, mediated by lysosome-localized O-GlcNAc transferase (OGT), elevating mature Cathepsin B in macrophages and its secretion in the tumor microenvironment (TME). Loss of OGT in macrophages reduces O-GlcNAcylation and mature Cathepsin B in the TME and disrupts cancer metastasis and chemoresistance. Human TAMs with high OGT are positively correlated with Cathepsin B expression, and both levels predict chemotherapy response and prognosis of individuals with cancer. Our study reports the biological and potential clinical significance of glucose metabolism in tumor-promoting TAMs and reveals insights into the underlying mechanisms.
Keywords: O-GlcNAc transferase; O-GlcNAcylation; cathepsin B; glucose metabolism; lysosome; metastasis; tumor-associated macrophages.
Copyright © 2022 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests The authors declare no competing interest.
Comment in
-
Metabolic regulation of Cathepsin B in tumor macrophages drives their pro-metastatic function.Cancer Cell. 2022 Oct 10;40(10):1079-1081. doi: 10.1016/j.ccell.2022.08.023. Epub 2022 Sep 15. Cancer Cell. 2022. PMID: 36113477
Similar articles
-
Hexosamine biosynthetic pathway promotes the antiviral activity of SAMHD1 by enhancing O-GlcNAc transferase-mediated protein O-GlcNAcylation.Theranostics. 2021 Jan 1;11(2):805-823. doi: 10.7150/thno.50230. eCollection 2021. Theranostics. 2021. PMID: 33391506 Free PMC article.
-
Glucose metabolism of TAMs in tumor chemoresistance and metastasis.Trends Cell Biol. 2023 Nov;33(11):967-978. doi: 10.1016/j.tcb.2023.03.008. Epub 2023 Apr 18. Trends Cell Biol. 2023. PMID: 37080816 Review.
-
Augmented TME O-GlcNAcylation Promotes Tumor Proliferation through the Inhibition of p38 MAPK.Mol Cancer Res. 2017 Sep;15(9):1287-1298. doi: 10.1158/1541-7786.MCR-16-0499. Epub 2017 May 23. Mol Cancer Res. 2017. PMID: 28536142
-
mTOR/MYC Axis Regulates O-GlcNAc Transferase Expression and O-GlcNAcylation in Breast Cancer.Mol Cancer Res. 2015 May;13(5):923-33. doi: 10.1158/1541-7786.MCR-14-0536. Epub 2015 Jan 30. Mol Cancer Res. 2015. PMID: 25636967 Free PMC article.
-
O-GlcNAcylation in Chronic Lymphocytic Leukemia and Other Blood Cancers.Front Immunol. 2021 Nov 18;12:772304. doi: 10.3389/fimmu.2021.772304. eCollection 2021. Front Immunol. 2021. PMID: 34868034 Free PMC article. Review.
Cited by
-
A new perspective on the therapeutic potential of tumor metastasis: targeting the metabolic interactions between TAMs and tumor cells.Int J Biol Sci. 2024 Sep 23;20(13):5109-5126. doi: 10.7150/ijbs.99680. eCollection 2024. Int J Biol Sci. 2024. PMID: 39430253 Free PMC article. Review.
-
Honokiol enhances the sensitivity of cetuximab in KRASG13D mutant colorectal cancer through destroying SNX3-retromer complex.Theranostics. 2024 Aug 26;14(14):5443-5460. doi: 10.7150/thno.97180. eCollection 2024. Theranostics. 2024. PMID: 39310106 Free PMC article.
-
Identification of a necroptosis-related gene signature for making clinical predictions of the survival of patients with lung adenocarcinoma.PeerJ. 2024 Jan 8;12:e16616. doi: 10.7717/peerj.16616. eCollection 2024. PeerJ. 2024. PMID: 38213773 Free PMC article.
-
O-GlcNAcylation: cellular physiology and therapeutic target for human diseases.MedComm (2020). 2023 Dec 19;4(6):e456. doi: 10.1002/mco2.456. eCollection 2023 Dec. MedComm (2020). 2023. PMID: 38116061 Free PMC article. Review.
-
Pan-Cancer Single-Cell and Spatial-Resolved Profiling Reveals the Immunosuppressive Role of APOE+ Macrophages in Immune Checkpoint Inhibitor Therapy.Adv Sci (Weinh). 2024 Jun;11(23):e2401061. doi: 10.1002/advs.202401061. Epub 2024 Apr 3. Adv Sci (Weinh). 2024. PMID: 38569519 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous
